Why the study?
Does an interarm systolic blood pressure difference ≥10 mmHg associate with atherosclerosis and left ventricular hypertrophy in patients?
Does an interarm systolic blood pressure difference ≥10 mmHg associate with atherosclerosis and left ventricular hypertrophy in patients?
Detection of an interarm SBP difference ≥10 mmHg provides a simple clinical method for identifying patients at increased risk of atherosclerosis and left ventricular hypertrophy.
Interarm SBP difference ≥10 mmHg may signal atherosclerosis and LVH; hypothesis-generating in cross-sectional data, needs prospective validation.
An interarm systolic blood pressure (SBP) difference of 10 mmHg or more have been associated with peripheral artery disease and adverse cardiovascular outcomes. We investigated whether an association exists between this difference and ankle-brachial index (ABI), brachial-ankle pulse wave velocity (baPWV), and echocardiographic parameters. A total of 1120 patients were included in the study. The bilateral arm blood pressures were measured simultaneously by an ABI-form device. The values of ABI and baPWV were also obtained from the same device. Clinical data, ABI<0.9, baPWV, echocariographic parameters, and an interarm SBP difference ≥10 mmHg were compared and analyzed. We performed two multivariate forward analyses for determining the factors associated with an interarm SBP difference ≥10 mmHg [model 1: significant variables in univariate analysis except left ventricular mass index (LVMI); model 2: significant variables in univariate analysis except ABI<0.9 and baPWV]. The ABI<0.9 and high baPWV in model 1 and high LVMI in model 2 were independently associated with an interarm SBP difference ≥10 mmHg. Female, hypertension, and high body mass index were also associated with an interarm SBP difference ≥10 mmHg. Our study demonstrated that ABI<0.9, high baPWV, and high LVMI were independently associated with an interarm SBP difference of 10 mmHg or more. Detection of an interarm SBP difference may provide a simple method of detecting patients at increased risk of atherosclerosis and left ventricular hypertrophy.
No takes yet. Share an insight, caveat, or question.
Su et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: